Search Results - "Özenirler, Seren"

Refine Results
  1. 1

    Serum liver fatty acid binding protein shows good correlation with liver histology in NASH by Özenirler, Seren, Degertekin, Ceyla Konca, Erkan, Gulbanu, Elbeğ, Şehri, Tuncer, Candan, Kandilc, Ugur, Akyol, Gulen

    Published in Hepato-gastroenterology (01-07-2013)
    “…Simple, reproducible and non-invasive tests that can be used to determine the severity of non-alcoholic steatohepatitis (NASH) are needed. Liver-type fatty…”
    Get more information
    Journal Article
  2. 2

    Diagnostic potential of serum direct markers and non-invasive fibrosis models in patients with chronic hepatitis B by Gümüşay, Özge, Özenirler, Seren, Atak, Ayşegül, Sönmez, Cemile, Özkan, Seçil, Tuncel, Ayşe Fıtnat, Yılmaz, Güldal, Akyol, Gülen

    Published in Hepatology research (01-03-2013)
    “…Aim:  Liver biopsy is recommended in the majority of patients with chronic viral hepatitis for fibrosis evaluation. Because of the disadvantages of liver…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Hepatitis B-related events in autologous hematopoietic stem cell transplantation recipients by Ceneli, Ozcan, Ozkurt, Zübeyde Nur, Acar, Kadir, Rota, Seyyal, Aki, Sahika Zeynep, Yeğin, Zeynep-Arzu, Yağci, Münci, Ozenirler, Seren, Sucak, Gülsan Türköz

    Published in World journal of gastroenterology : WJG (14-04-2010)
    “…AIM: To investigate the frequency of occult hepatitis B, the clinical course of hepatitis B virus (HBV) reactivation and reverse seroconversion and associated…”
    Get full text
    Journal Article
  5. 5

    HBV-related events after allogeneic hematopoetic stem cell transplantatıon in a center from Turkey by Çakar, Merih Kızıl, Suyanı, Elif, Sucak, Gülsan Türköz, Altındal, Şermin, Akı, Şahika Zeynep, Acar, Kadir, Yağcı, Münci, Rota, Seyyal, Özenirler, Seren

    Published in Annals of hematology (01-03-2013)
    “…To investigate the frequency of hepatitis B virus (HBV)-related events after allogeneic HCT in a moderate endemic area for HBV infection. The data of 197…”
    Get full text
    Journal Article
  6. 6

    Serum levels of advanced oxidation protein products, malonyldialdehyde, and total radical trapping antioxidant parameter in patients with chronic hepatitis C by Ozenırler, Seren, Erkan, Gülbanu, Gülbahar, Ozlem, Bostankolu, Ozge, Ozbaş Demırel, Ozlem, Bılgıhan, Ayşe, Akyol, Gülen

    Published in The Turkish journal of gastroenterology (01-02-2011)
    “…Oxidative stress increases in chronic hepatitis C, and antioxidant defense mechanisms are impaired. The aims of this study were to compare chronic hepatitis C…”
    Get full text
    Journal Article
  7. 7

    Double-blinded, randomized, placebo-controlled study to evaluate the effectiveness of sulphasalazine in preventing acute gastrointestinal complications due to radiotherapy by Kiliç, Diclehan, Egehan, İbrahim, Özenirler, Seren, Dursun, Ayşe

    Published in Radiotherapy and oncology (01-11-2000)
    “…Background and purpose: Acute radiation-induced diarrhea occurs in approximately 80% of the patients receiving pelvic radiotherapy. It is caused by…”
    Get full text
    Journal Article
  8. 8

    Diagnostic performance of 2D shear wave elastography in predicting liver fibrosis in patients with chronic hepatitis B and C: a histopathological correlation study by Aksakal, Mehmet, Oktar, Suna Ozhan, Sendur, Halit Nahit, Esendaglı, Güldal, Ozenirler, Seren, Cindoruk, Mehmet, Hızel, Kenan

    Published in Abdominal radiology (New York) (01-07-2021)
    “…Purpose In this study, we investigated the diagnostic efficacy of 2D-Shear Wave Elastography ( 2D-SWE) in detecting stages of liver fibrosis and determining…”
    Get full text
    Journal Article
  9. 9

    Risk factors for hepatocellular carcinoma in Turkey by UZUNALIMOGLU, Ozden, YURDAYDIN, Cihan, TÖZÜN, Nurdan, DEGERTEKIN, Halil, ÖKTEN, Atilla, CETINKAYA, Hülya, BOZKAYA, Hakan, SAHIN, Tülin, COLAKOGLU, Salih, TANKURT, Ethem, SARIOGLU, Mustafa, OZENIRLER, Seren, AKKIZ, Hikmet

    Published in Digestive diseases and sciences (01-05-2001)
    “…The contribution of hepatitis B, hepatitis C, and excess alcohol intake to the development of hepatocellular carcinoma in Turkey was assessed. The study was…”
    Get full text
    Journal Article
  10. 10

    A patient with primary biliary cirrhosis accompanied by Graves disease and Hurthle cell adenoma by Yaşar, Demet G, Ozenirler, Seren, Doğan, Mehmet

    Published in The Turkish journal of gastroenterology (01-09-2007)
    “…A case of Hurthle cell adenoma and Graves disease associated with primary biliary cirrhosis is reported in a 51-year-old woman, who developed elevated liver…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Importance of cytokines, oxidative stress and expression of BCL-2 in the pathogenesis of non-alcoholic steatohepatitis by Torer, Nihan, Ozenirler, Seren, Yucel, Aysegul, Bukan, Neslihan, Erdem, Ozlem

    Published in Scandinavian journal of gastroenterology (01-01-2007)
    “…Objective. Non-alcoholic steatohepatitis (NASH) is a form of chronic hepatitis. The pathogenesis of NASH has been dealt with in only a few studies and so it…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Comparative diagnostic accuracy of red cell distribution width-to-platelet ratio versus noninvasive fibrosis scores for the diagnosis of liver fibrosis in biopsy-proven nonalcoholic fatty liver disease by Cengiz, Mustafa, Ozenirler, Seren

    “…OBJECTIVENonalcoholic fatty liver disease (NAFLD) is a chronic liver disease and assessment of liver fibrosis is important. We aimed to investigate the…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Role of serum toll-like receptors 2 and 4 in non-alcoholic steatohepatitis and liver fibrosis by Cengiz, Mustafa, Ozenirler, Seren, Elbeg, Sehri

    Published in Journal of gastroenterology and hepatology (01-07-2015)
    “…Background and Aim Non‐alcoholic fatty liver disease is a common cause of chronic liver disease, including non‐alcoholic steatohepatitis (NASH). Our aim was to…”
    Get full text
    Journal Article
  17. 17

    Serum and Ascitic Fluid Superoxide Dismutase and Malondialdehyde Levels in Patients with Cirrhosis by Ozenirler, Seren, Sancak, Banu, Coskun, Ugur

    Published in Biomarker insights (12-03-2008)
    “…Serum and ascitic fluid superoxide dismutase (SOD) and malondialdehyde (MDA) levels were measured in 43 patients with cirrhosis and in a 10 healthy control…”
    Get full text
    Journal Article
  18. 18

    Serum and Ascitic Fluid Superoxide Dismutase and Malondialdehyde Levels in Patients with Cirrhosis by Ozenirler, Seren, Sancak, Banu, Coskun, Ugur

    Published in Biomarker insights (2008)
    “…Seren Ozenirler1, Banu Sancak2 and Ugur Coskun3 1Gastroenterology, Gazi University Medical School, Ankara, Turkey. 2Biochemistry, Gazi University Medical…”
    Get full text
    Journal Article
  19. 19

    Serum β-trophin level as a new marker for noninvasive assessment of nonalcoholic fatty liver disease and liver fibrosis by Cengiz, Mustafa, Ozenirler, Seren, Kocabiyik, Murat

    “…OBJECTIVENonalcoholic fatty liver disease (NAFLD) is a common chronic liver disease and evaluation of fibrosis is important. We aimed to investigate the…”
    Get full text
    Journal Article
  20. 20